Results 211 to 220 of about 2,385,649 (308)

La mort cel·lular en el desenvolupament del sistema nerviós [PDF]

, 1996
Boix Torras, Jacint, Calderó i Pardo, Jordi, Esquerda, Josep E., Ribera, Joan   +3 more
core  

Tropomyosin 3 Gene Fusions in Cancers: From Mechanisms to Treatments-A Comprehensive Review. [PDF]

Cancer Med
Chen A, Li S, Guo C, Gu C, Gui J, Deng Y, Feng X, Mi Y.   +7 more
europepmc   +1 more source

Advances in Tissue-Agnostic Targeting in Cancer Therapeutics: Current Approvals, Challenges, and Future Directions. [PDF]

Oncol Res
Rubinstein M, Hong ML, Nanda RK, Jones DT, Aboaid H, Myat YM, Thein KZ.   +6 more
europepmc   +1 more source

The development of neurotrophin receptor Trk immunoreactivity in the retina of the zebrafish (Brachydanio rerio)

, 1994
Julie H. Sandell, Stella C. Martin, Gerhard Heinrich   +2 more
openalex   +1 more source

Els Receptors de tirosina quinasa trk : activitat oncogènica i neurotròfica [PDF]

, 1993
Barbacid Montalbán, Mariano
core  

Modulation of BDNF/TrkB Signalling Pathway in Alzheimer's Disease: Mechanistic Insights and the Role of Stem Cell Therapy. [PDF]

Biomedicines
Harun ZZ, Abdul Azhar A, Kim YJ, Ibrahim FW, Ng MH, Tan JK, Lokanathan Y.   +6 more
europepmc   +1 more source

Activation of Trk Neurotrophin Receptor Signaling by Pituitary Adenylate Cyclase-activating Polypeptides

, 2002
Francis S. Lee, Rithwick Rajagopal, Albert H. Kim, P Chang, Moses V. Chao   +4 more
openalex   +1 more source

Identification of a novel <i>PRUNE2::NTRK2</i> gene fusion in soft tissue sarcoma patients-friend or foe? Case series. [PDF]

Ther Adv Med Oncol
Bobak K, Tysarowski A, Seliga KA, Pia̧tkowski J, Golik P, Spałek MJ, Szumera-Ciećkiewicz A, Rutkowski P, Czarnecka AM.   +8 more
europepmc   +1 more source

Evolving Therapeutic Landscape of ROS1-Positive Non-Small Cell Lung Cancer: An Updated Review. [PDF]

Curr Oncol
Bischoff H, Gendarme S, Somme L, Chouaid C, Schott R.   +4 more
europepmc   +1 more source

Clinical Benefit From Molecularly Guided Cancer Care: A Matching-Adjusted Indirect Comparison of Larotrectinib Versus Standard of Care. [PDF]

JCO Precis Oncol
Bokemeyer C, Abrams KR, Garcia-Foncillas J, Italiano A, Lassen U, Linsell L, Marian M, Paracha N, Sullivan SD, Brega N, Thompson J.   +10 more
europepmc   +1 more source